Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P U Feig

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
The Journal of Antimicrobial Chemotherapy|September 1, 1982
Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycinP U Feig, P P Mitchell, E Abrutyn, et al.
Diabetes, Obesity & Metabolism|January 29, 2011
Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndromeP U Feig, S Shah, A Hermanowski-Vosatka, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
The Journal of Antimicrobial Chemotherapy|September 1, 1982
Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycinP U Feig, P P Mitchell, E Abrutyn, et al.
Diabetes, Obesity & Metabolism|January 29, 2011
Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndromeP U Feig, S Shah, A Hermanowski-Vosatka, et al.
Pageof 4